Relief for Novartis’s Entresto In India Challenge But More To Come?
Executive Summary
Novartis secures injunction order against alleged infringers of heart failure therapy Entresto in India. Court also makes key observations around the “scientific opinion”, which had gone in favor of challenger Natco.